LiveWire

Focused on protecting enterprise data, Varonis developed a security software platform that performs user behavior analytics that analyzes and detects threats and cyberattacks. Using machine learning technology as a key enabler, Varonis’s mission is to protect sensitive information for their customers. Varonis has been an index member of THNQ since inception, with shares up over 120% in the past 12 months. In that time period, Varonis has delivered double-digit revenue growth and demonstrated its operating leverage by posting a 15% operating margin in the most recent quarter, compared to a negative operating margin just a year ago. - ROBO Global

Brooks Automation, the leading provider of automation solutions for semiconductor manufacturing and life sciences, continues to deliver stunning returns. Its share price has more than doubled in the past twelve months and octupled – yes, an eight-bagger – since its inclusion in ROBO in 2014. Brooks made its name as one the world’s top suppliers of automation equipment for the semiconductor industry with especially strong positions in silicon wafer-handling robots and contamination control, a highly profitable business generating over $500 million in annual revenue today. - ROBO Global

Analysts expect PayPal’s  bid for more growth -- particularly through its ground-breaking move into cryptocurrency -- will be a key focus at the event on Thursday. Shares have soared 135% in the past year, propelled by a shift to digital commerce amid the pandemic. Its market value of about $331 billion exceeds most large banks, including Bank of America Corp., Citigroup Inc. and Wells Fargo & Co., and almost matches Mastercard Inc.’s of $332 billion. The stock touched an all-time high on Feb. 9 as Bitcoin blew past another record. Shares also rose after better-than-expected earnings last week. - Bloomberg

The total ridership is plunging, as the company reported a 51% drop in January year to year. However, Lyft keeps getting closer to break-even, as each customer is bringing more revenue and a bigger contribution margin to to the company. 

It comes on top of a roughly 6% stake in PacBio that SoftBank had already accumulated and will give the Japanese investor significant sway over the Menlo Park, Calif., company. PacBio has a market value of $7.4 billion after a dramatic jump in its shares in recent months that was sparked in part by a new joint venture with Invitae Corp., a medical-genetics company. PacBio, whose shares are up 11-fold since July, has also brought in new management, including a chief executive. - WSJ